Last quarter (Q4 2022), Argent Biopharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Argent Biopharma's net income was $―. See Argent Biopharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Total Revenue	$ ―	$ 891.08K	$ 3.39M	$ 4.73M	$ 2.96M	$ 2.08M
Cost of Revenue	$ ―	$ 687.39K	$ 1.94M	$ 2.92M	$ 1.65M	$ 1.90M
Gross Profit	$ ―	$ 203.70K	$ 1.45M	$ 1.81M	$ 1.31M	$ 174.66K
Operating Expense	$ ―	$ 18.87M	$ 18.33M	$ 16.24M	$ 13.38M	$ 11.98M
Operating Income	$ ―	$ -18.67M	$ -16.88M	$ -14.43M	$ -12.07M	$ -11.80M
Net Non Operating Interest Income Expense	$ ―	$ -480.55K	$ -262.02K	$ -209.84K	$ 361.50K	$ 123.25K
Other Income Expense	$ ―	$ -784.28K	$ -642.73K	$ 1.23M	$ -3.01M	$ -6.84M
Pretax Income	$ ―	$ -17.55M	$ -12.07M	$ -21.25M	$ -15.44M	$ -18.77M
Tax Provision	$ ―	$ ―	$ 2.02K	$ ―	$ -27.28K	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -17.53M	$ -11.76M	$ -20.83M	$ -15.87M	$ -19.36M
Basic EPS	$ ―	$ -0.47	$ -0.01	$ -0.01	$ -0.01	$ -0.01
Diluted EPS	$ ―	$ -0.47	$ -0.01	$ -0.01	$ -0.01	$ -0.01
Basic Average Shares	$ ―	$ 37.01M	$ 2.95B	$ 2.57B	$ 1.91B	$ 1.38B
Diluted Average Shares	$ ―	$ 37.01M	$ 2.95B	$ 2.57B	$ 1.91B	$ 1.38B
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ 19.56M	$ 20.27M	$ 19.16M	$ ―	$ ―
Net Income From Continuing And Discontinued Operation	$ ―	$ -17.53M	$ -11.76M	$ -20.83M	$ -15.87M	$ -19.36M
Normalized Income	$ ―	$ -13.98M	$ -14.21M	$ -12.23M	$ -11.08M	$ -10.09M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ ―	$ -17.07M	$ -11.80M	$ -21.04M	$ -15.07M	$ -18.63M
EBITDA	$ ―	$ -15.77M	$ -11.05M	$ -20.90M	$ -14.58M	$ -18.15M

Currency in USD

Argent Biopharma Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing